Partnership Opportunities
Our goal is to create partnerships with companies to help minimize their investment risk by providing the research environment, expertise, clinical samples and joint funding to conduct the preclinical and early-stage clinical research necessary to find treatments that would otherwise be ignored in the traditional for-profit, drug-development process. We see this as a revolutionary business model that will accelerate access to treatment for pediatric patients.
Potential partnerships are available in these areas:
Therapeutics
- ADHD
- Allergy and Asthma – Mast Cells
- Asthma
- Asthma and Lung Inflammation
- Bone Disorders and Malformations
- Brain Malformations
- Cancer, Autoimmunity, and Infectious Disease – Macrophage Regulation
- Cancer – Cadherin-Mediated Interventions
- Cancer – Improved CAR T Targeting
- Cancer – Macrophage Regulation
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cancer – Small Molecules for CAR T
- Cancer – T cell conditioning
- Cancer – Target Validation
- Cell and Gene Therapies
- Cerebellar Development
- Chronic Pain
- Concussion
- Congenital Disorders of Glycosylation
- COVID-19 – Diagnostic for Immunity
- COVID-19 and Other Viral Diseases
- Craniofacial Malformations – Clinical Data
- Cryptosporidium and Other Parasites
- Dravet – Advanced Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Group B Streptococcus
- Heart Arrhythmia
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemophilia – Immunomodulation Therapy
- Hemophilia – Intraosseous Lentiviral Therapy
- HIV Microbiomes
- HIV – CAR-T therapies
- HIV – Diagnostics
- HIV – Viral Reservoirs
- HIV – Transmission and Progression
- Hypoplastic Left Heart Syndrome
- Infantile Hemangiomas and Other Vascular Malformations
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Inflammatory Bowel Disease – Cadherin-Mediated Interventions
- Inflammatory Bowel Disease – Dietary Modifications
- Influenza – Vaccines
- Kawasaki Disease
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Lymphatic Malformations
- Lysosomal Storage Diseases – Newborn Screening
- Malaria – Dormant Liver Form
- Malaria – Host-Pathogen Interactions
- Malaria – Human Immune Response
- Malaria – Molecular Mechanisms
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Mitochondrial Diseases – Mouse Model and Patient Cell Lines
- Motor Impairments and Paralysis
- Nontuberculous Mycobacterial Diseases – Drug Discovery
- Obesity
- Pain
- Peroxisomal Disorders
- Retinal Disorders
- Stroke – Neurovascular Imaging
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Drug Discovery
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis and Nontuberculosis Mycobacterial Diseases
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Diagnostics
- Autism – Characterizing Protein Interactions
- Cancer – Macrophage Regulation
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Concussion
- Congenital Disorders – Mosaic Mutations
- COVID-19 – Diagnostic for Immunity
- Healthcare Associated Infections
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Immunoreactivity and Tolerance
- HIV – Diagnostics
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Infantile Hemangiomas and Other Vascular Malformations
- Kawasaki Disease
- Lupus – B-Cell Targets
- Metabolic Disorders – Newborn Screening
- Retinal Disorders
- Sepsis
- Sleep Apnea
- Tuberculosis and Antimicrobial-Resistance
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Medical Devices
- Activity Trackers and Apps
- Craniofacial Malformations – Clinical Data
- Epilepsy – Medical Device Interventions
- Heart Arrhythmia
- Hemophilia – Gene Therapy
- Hypoplastic Left Heart Syndrome
- Malaria – Insect Dissection Tool
- Motor Impairments and Paralysis
- Sleep Apnea
Vaccines
- COVID-19 and Other Viral Diseases
- Group B Streptococcus
- HIV Tissue Reservoirs
- HIV – Transmission and Progression
- Infectious Diseases – Immune Development
- Influenza – Vaccines
- Malaria – Dormant Liver Form
- Malaria – Human Immune Response
- Malaria – P. falciparum and P. vivax
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Tuberculosis
- Tuberculosis and Nontuberculous Mycobacterial Diseases
Research Tools and Understanding Disease Pathways
- Addiction – Characterizing Pathways
- Allergy and Asthma – Mast Cells
- Anesthesia Risks
- Autism – Characterizing Protein Interactions
- Asthma
- Asthma and Lung Inflammation
- Bone Disorders and Malformations
- Brain Overgrowth Diseases
- Brain Malformations
- Breathing Dysregulation
- Cancer, Autoimmunity, and Infectious Disease – Macrophage Regulation
- Cancer – Cadherin-Mediated Interventions
- Cancer – Improved CAR T Targeting
- Cancer – Macrophage Regulation
- Cancer – Mouse Model for CAR-T Therapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cancer – Small Molecules for CAR T
- Cancer – Target Validation
- Cell and Gene Therapies
- Cerebellar Development
- Congenital Disorders of Glycosylation
- Congenital Disorders – Mosaic Mutations
- COVID-19 – Diagnostic for Immunity
- Cryptosporidium and Other Parasites
- Dravet – Advanced Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Food Insecurity and Chronic Disease Management
- Healthcare Associated Infections
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- HIV and Other Infectious Diseases – B-cell Sequencing
- HIV Microbiomes
- HIV Tissue Reservoirs
- HIV – Transmission and Progression
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Hypoplastic Left Heart Syndrome
- Infectious Diseases – Immune Development
- Infectious and Neurodegenerative Diseases: Interactomes
- Inflammatory Bowel Disease – Cadherin-Mediated Interventions
- Influenza – Vaccines
- Lupus – B-Cell Integrins
- Lupus – B-Cell Targets
- Lysosomal Storage Diseases – Newborn Screening
- Malaria – Dormant Liver Form
- Malaria – Host Pathogen Interactions
- Malaria – Human Immune Response
- Malaria – Insect Dissection Tool
- Malaria – Molecular Mechanisms
- Malaria – P. falciparum and P. vivax
- Malaria – Vaccines, Therapies, Drug Resistance
- Malaria and HIV – Monoclonal Antibodies
- Metabolic Disorders – Newborn Screening
- Mitochondrial Disease
- Mitochondrial Diseases – Mouse Model and Patient Cell Lines
- MRSA Infections
- Nontuberculous Mycobacterial Diseases – Drug Discovery
- Obesity
- Organ Development
- Peroxisomal Disorders
- Retinal Disorders
- Sepsis
- Sleep Apnea
- Stroke
- Stroke – Neurovascular Imaging
- Trypanosomal Diseases
- Tuberculosis
- Tuberculosis – Drug Discovery
- Tuberculosis – Phosphosignaling Pathways
- Tuberculosis and Antimicrobial-Resistance
- Wilson Disease and Other Lysosomal Storage Diseases – Newborn Screening
Educational Products and Digital Health
- Activity and Fitness
- Activity Trackers and Apps
- ADHD
- Adolescent-Focused Digital Health Interventions
- Inflammatory Bowel Disease – Dietary Modifications
- Pain
- Sleep Science – Researching Child, Adolescent and Family Sleep
Learn More
To learn more about partnering with Seattle Children’s Research Institute, or if you’re a Seattle Children’s researcher looking for industry partners. please contact:
Dr. Elizabeth Aylward
Director, Office of Science–Industry Partnerships
Email
206-844-1065
